PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
March 4, 2026Open Access

Thrombopoietin Receptor Agonists Plus Immunosuppressive Therapy in Aplastic Anaemia: A Systematic Review and Meta-Analysis.

View Full Paper
Ask AI
Bookmark
Share

Authors

EAElham AshrafiLYLauren YoungLFLucy C. Fox

Discussion

Loading...

Member takes

Overview

Systematic review shows potential benefits of combining thrombopoietin receptor agonists with immunosuppressive therapy in aplastic anaemia, highlighting treatment options.

Key Points

  • To evaluate the efficacy of thrombopoietin receptor agonists combined with immunosuppressive therapies for treating aplastic anaemia.
  • Conducted a systematic review of relevant clinical trials.
  • Performed a meta-analysis to assess combined treatment effects.
  • Included studies that test thrombopoietin receptor agonists and immunosuppressive therapy.
  • Indicated improved response rates in patients receiving combined treatment.
  • Showed increased recovery of platelet counts in the treatment group.
  • Highlighted potential benefits without significant additional risks.

Cite This Study

Ashrafi et al. (2026) studied this question.

synapsesocial.com/papers/69a7cc4cd48f933b5eed7e8chttps://doi.org/10.1002/jha2.70226
View Full Paper
Ask AI
Bookmark
Share